Publications

Year of Publicationsort ascending Title Faculty Association
2021 Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. John M. Streicher, PhD
2021 Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. Edita Navratilova, Frank Porreca, PhD
2021 Sex hormones regulate NHE1 functional expression and brain endothelial proteome to control paracellular integrity of the blood endothelial barrier. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2021 ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2020 The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. John M. Streicher, PhD
2020 Editorial: Novel Molecular Targets for the Treatment of Pain. John M. Streicher, PhD
2020 Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model. Torsten Falk, Ph.D., Robin Polt, Ph.D., Todd Vanderah, PhD
2020 Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models. Tally Largent-Milnes, PhD, John M. Streicher, PhD
2020 Daily intermittent fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation. John M. Streicher, PhD
2020 Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake. Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Multifaceted roles of TAK1 signaling in cancer. Nam Lee, Ph.D.
2020 DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache. Kelly L Karlage, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection. Christopher Cartmell
2020 Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy. Fei Yin, Ph.D.
2020 Childbearing Decisions in Residency: A Multicenter Survey of Female Residents. Sigrid Gardner Williams
2020 Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2020 A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models. John M. Streicher, PhD
2020 The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2020 Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising. Todd Vanderah, PhD
2020 Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2020 Potential therapeutic treatments of cancer-induced bone pain. Todd Vanderah, PhD
2020 Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation. Todd Vanderah, PhD
2020 Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment. Fei Yin, Ph.D.

Pages